Stærk Marianne Gardar, Kaderly Rasmussen Emma L, Hannibal Charlotte Gerd, Hertzum-Larsen Rasmus, Baandrup Louise, Kjær Susanne K
Unit of Virus, Lifestyle and Genes, Danish Cancer Institute, Copenhagen, Denmark.
Department of Pathology, Zealand University Hospital Roskilde, Roskilde, Denmark.
Int J Cancer. 2025 Apr 18. doi: 10.1002/ijc.35454.
Lichen sclerosus (LSc) is a chronic inflammatory disease affecting the anogenital area and having malignant potential. Population-based data on the incidence of LSc in men and associated cancer risk are sparse. In the Danish Pathology Register, we identified all men with histologically verified penile LSc 1997-2022 and calculated incidence rates. Through linkage with the Danish Cancer Registry, standardized incidence ratios (SIRs) with 95% confidence intervals (CIs) were computed as relative risk estimates of penile squamous cell carcinoma (SCC) and non-penile cancer in men with penile LSc (1978-2019) compared with background population rates. During the study period, the age-standardized incidence rate of penile LSc more than doubled, being 17.9 per 100,000 person-years in the most recent time (2021-2022). The age-specific incidence increased with age and was highest in ages 70-79 years (29.2 per 100,000 person-years). Compared with the general population, men with penile LSc had an increased rate of penile SCC (SIR = 15.5, 95% CI: 12.0-19.5), which increased with follow-up length and younger age at LSc diagnosis. Rates of non-penile cancers were mostly close to unity except for lung cancer (SIR = 0.6, 95% CI: 0.5-0.7). This nationwide study showed an increased incidence of histologically verified penile LSc over the past 26 years. Importantly, men with penile LSc had nearly 16 times higher rate of penile SCC compared with the general population. There was no strong association with the non-penile cancers, except for a lower rate of lung cancer, suggesting that the malignant potential of LSc is caused by local factors rather than a general cancer predisposition.
硬化性苔藓(LSc)是一种影响肛门生殖器区域且具有恶变潜能的慢性炎症性疾病。关于男性LSc发病率及相关癌症风险的基于人群的数据较为匮乏。在丹麦病理登记处,我们识别出1997年至2022年所有经组织学证实患有阴茎LSc的男性,并计算发病率。通过与丹麦癌症登记处的关联,计算出标准化发病率(SIRs)及95%置信区间(CIs),作为阴茎LSc男性(1978年至2019年)阴茎鳞状细胞癌(SCC)和非阴茎癌相对于背景人群发病率的相对风险估计值。在研究期间,阴茎LSc的年龄标准化发病率增加了一倍多,最近时期(2021年至2022年)为每10万人年17.9例。特定年龄发病率随年龄增长而增加,在70至79岁年龄段最高(每10万人年29.2例)。与普通人群相比,阴茎LSc男性的阴茎SCC发病率增加(SIR = 15.5,95% CI:12.0 - 19.5),且随随访时间延长和LSc诊断时年龄较小而增加。除肺癌外(SIR = 0.6,95% CI:0.5 - 0.7),非阴茎癌发病率大多接近1。这项全国性研究表明,在过去26年中,经组织学证实的阴茎LSc发病率有所增加。重要的是,阴茎LSc男性的阴茎SCC发病率比普通人群高近16倍。除肺癌发病率较低外,与非阴茎癌没有很强的关联,这表明LSc的恶变潜能是由局部因素而非一般癌症易感性引起的。